WebJun 13, 2024 · This is the first commercially available molecular test that can guide treatment decisions for gonorrhea infections, giving doctors and patients the option of using a simple oral dose of ciprofloxacin instead of ceftriaxone injection, one of the last remaining antibiotics available for multi-drug resistant infections. WebAug 5, 2024 · SYDNEY-- ( BUSINESS WIRE )--SpeeDx Pty. Ltd., the developer of transformative new molecular diagnostic solutions, today announced it had raised up to US $10 million in additional equity...
SpeeDx Gets CE-IVD Mark for Antibiotic-Resistant Gonorrhea MDx
WebDec 6, 2024 · NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx announced on Thursday that it has received CE-IVD marking for a qPCR assay to detect both Neisseria gonorrhoeae and sequences in the gyrA gene of the bacteria linked to … WebApr 1, 2024 · SpeeDx has developed a rapid, molecular test using polymerase chain reaction (PCR) technology called InSignia™, to assist in detecting chlamydia and active infection … commark cleaning
Evaluation of the SpeeDx ResistancePlus® GC and …
WebDec 6, 2024 · SpeeDx Receives CE-IVD Mark for ResistancePlus® GC Gonorrhea Test. New molecular assay enables rapid antibiotic resistance result to support use of cost effective … WebAug 10, 2024 · Australian diagnostics company SpeeDx has a point-of-care device that tests for gonorrhea and for the wild-type and mutant forms of the gyrA 91 gene. Klausner said … WebSpeeDx analysis software included in contract pricing is license free and installed on a high security and GDPR compliant platform: audit trails; user traceability; LIS connectivity; QA and batch management; Increase capacity of your existing qPCR instrumentation through … dry out ears